PATENT CLAIM ANALYSIS

Application Number: 15778213
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "492000"]

Abstract:
Disclosed herein, inter alia, are platinum-based compounds useful for treating cancer.

Claim (Index 18):
The method of  claim 16 , wherein said cancer is osteosarcoma, neuroblastoma, or rhabdomyosarcoma.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15760959', '14175295', '15757238', '15614278', '14849428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.813556589765163
- 35 USC 102 Novelty (BERT): 0.5657630999583034
- Combined Prediction Score: 0.788777240784477
- Mean Citation Score: 462.703324
- Max Citation Score: 476.58414000000016
- Similarity Product: 313.4110693816925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test